Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring the Therapeutic Efficacy of the Combinations Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 5 Years of Age in Five Sentinel Sites in Mozambique

NCT05343312 is registered in ClinicalTrials.gov with Centro de Investigacao em Saude de Manhica as lead sponsor.

NCT NCT05343312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring the Therapeutic Efficacy of the Combinations Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 5 Years of Age in Five Sentinel Sites in Mozambique
Lead sponsor
Centro de Investigacao em Saude de Manhica
Phase
Phase 4
Overall status
Completed
Start date
March 16, 2022
Completion date
July 30, 2025
Enrollment
870 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malaria